Neurogene shares owned by Summit Investment Advisors
Quarter-by-quarter ownership of Neurogene (NGNE) shares owned by Summit Investment Advisors
from 13F filings
Historical chart of Summit Investment Advisors investment in Neurogene
Tip: Access up to 7 years of quarterly data
All positions including Neurogene held by Summit Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Neurogene by Summit Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $18k | 1.0k | 17.33 |
| 2025-06-30 | $15k | 1.0k | 14.95 |
| 2025-03-31 | $12k | 1.0k | 11.71 |
| 2024-12-31 | $23k | 1.0k | 22.86 |
| 2024-09-30 | $42k | 1.0k | 41.96 |
| 2024-06-30 | $37k | 1.0k | 36.39 |
More positions owned by Summit Investment Advisors
View all positions for Summit Investment Advisors